September 20th 2024
Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Legal issues complicate cosmetic laser treatments
June 1st 2006Common legal issues facing physicians who perform cosmetic laser treatments include medical malpractice, as well as issues related to physician extenders and the Health Insurance Portability and Accountability Act (HIPAA), an expert says.
Spend time considering pros, cons of modality's 'fit' in your practice
June 1st 2006As new cosmetic treatments are introduced and physicians' understanding of existing treatments grows, determining whether a particular technology fits in one's practice requires evaluating arguments both pro and con, says the president of the American Society for Laser Medicine and Surgery (ASLMS).
Laser, light treatments expanding, combining modalities
June 1st 2006Key developments from the recent American Society for Laser Medicine and Surgery (ASLMS) meeting include broader applications for existing devices and the growing availability of treatments that combine modalities, sources tell Dermatology Times.
Cancer & the skin Managing the cutaneous side effects of cancertreatments
May 1st 2006National report - Chemotherapy and radiation can createunwanted results ranging from hair loss to pigment problems.However, an expert tells Dermatology Times that with some newbiologically targeted cancer therapies, skin-related side effectsseem to provide a barometer of these treatments' effectiveness.
More than lip service: Lower face options minimize downtime
May 1st 2006National report - For treating the lips and lower face,experts tell Dermatology Times that options including fillers,botulinum toxin injections and newer resurfacing technologies candeliver excellent cosmetic results usually with little or nodowntime.
Lipodissolve ideal option for post-liposuction irregularities
May 1st 2006Las Vegas - Lipodissolve, a treatment some doctors believe tobe a form of mesotherapy, is evolving to be highly effective fortreatment of post-liposuction irregularities and cellulite, but thetherapy is not a replacement for liposuction and proper training isessential, according to Barry Lycka, M.D., speaking at the annualmeeting of the American Society of Cosmetic Dermatology andAesthetic Surgery here.
Soft-tissue augmentation need not be a bruising experience
May 1st 2006National report - While soft-tissue fillers offer the uniquebenefit of providing fast correction for busy patients who don'twant to have the down-time for a face-lift, bruising can throw amonkey wrench into the best-laid plans for stellar patientsatisfaction.
Biafine offers innovative wound healing solution
May 1st 2006Las Vegas - The new wound healing product Biafine (OrthoNeutrogena), gaining popularity among radiation oncologists for the treatment of radiation dermatitis, also offers an innovative option for dermatologists in treating problems ranging from sunburn to superficial wounds, according to Diane Berson, M.D., speaking at the annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery here.
Imiquimod/LN effective treatment for some skin cancers
May 1st 2006Houston - For the general dermatologist, the mainstay of safeand effective skin cancer management is dependent upon sensibleclinical judgment, says Deborah MacFarlane, M.D., associateprofessor of dermatology and plastic surgery at the University ofTexas Medical School at Houston, and MD Anderson Cancer Center.
PDA advances research, treatment for pigmentary disorders
May 1st 2006Hong Kong - Members of the Pigmentary Disorders Academy (PDA)discussed a spectrum of topical issues, finalized revisions tomanuscripts for a supplement to the Journal of the American Academyof Dermatology, and decided to undertake a global, community-basedsurvey investigating the natural history of melasma as the nextmajor project when the group convened its third annual meetinghere.
Allergan-Inamed merger changes cosmetic playing field
May 1st 2006National report - As if keeping track of the expanding rosterof fillers and neurotoxins wasn't enough for dermatologists andcosmetic surgeons, the Federal Trade Commission (FTC)'s nod towardAllergan's estimated $3.4 billion buyout of aesthetic rival Inamedinjects an anything-but-paralyzing wrinkle into what some industrypundits call a quest to deliver "total facial rejuvenation."
Synthetic polymer found effective in treating 'facial wasting' in some HIV sufferers
April 6th 2006Padua , Italy -- Researchers at the University of Padua report that injections of a synthetic polymer may be helpful in treating some HIV patients' facial wasting associated with combination antiretroviral therapy.